nach oben

Wiener klinische Wochenschrift

Erschienen in:

01.06.2017 | original article

Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer

verfasst von: Haiyi Hu, Yuebing Chen, Sheng Cheng, Gonghui Li, Zhigen Zhang

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 11-12/2017

Einloggen, um Zugang zu erhalten

Summary

Background

The homeobox (HOX) genes have been implicated playing important roles in many human cancers. HOXA13 is a member of HOX genes that encode transcription factors regulating embryonic development and cell fate. In the present study, we aimed to investigate the expression and prognostic significance of HOXA13 in bladder cancer.

Methods

Immunohistochemical staining was initially performed to screen the differentially expressed HOXA13 between bladder cancer tissues and paired adjacent non-cancerous tissues. Subsequent Western blotting analysis validation was conducted using tissue samples from patients with bladder cancer.

Results

The expression level of HOXA13 was significantly higher in bladder cancer tissues compared to that in adjacent non-cancerous tissues (P < 0.001). The χ²-test showed that expression of HOXA13 was positively correlated with lymphatic metastasis (P = 0.013), bladder tumor TNM stage (P = 0.002) and pathological grade (P < 0.001). Kaplan-Meier survival analysis revealed that patients with bladder cancer with high expression of HOXA13 had shorter overall survival time (P = 0.001) and disease-free survival time (P = 0.001) compared to patients with low expression of HOXA13. Multivariate analysis indicated that HOXA13 was an independent prognostic factor for overall survival for bladder cancer patients.

Conclusions

The results of our study show that high expression of HOXA13 is associated with the progression of bladder cancer and that HOXA13 might serve as a biomarker for prognosis of bladder cancer.

Vorheriger Artikel Impact of gender on tumor stage and survival of upper urinary tract urothelial cancer

Nächster Artikel A 5‑year update of patients with HPV positive versus negative oropharyngeal cancer after radiochemotherapy in Austria

Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jemal A. International variations in bladder cancer incidence and mortality. Eur Urol. 2014;66(1):1059–73.CrossRef

Seifert A, Werheid DF, Knapp SM, Tobiasch E. Role of Hox genes in stem cell differentiation. World J Stem Cells. 2015;7(3):583–95.CrossRefPubMedPubMedCentral

Javed S, Langley SE. Importance of HOX genes in normal prostate gland formation, prostate cancer development and its early detection. BJU Int. 2014;113(4):535–40.CrossRefPubMed

Cantile M, Franco R, Schiavo G, Procino A, Cindolo L, Botti G, et al. The HOX genes network in uro-genital cancers: mechanisms and potential therapeutic implications. Curr Med Chem. 2011;18(32):4872–84.CrossRefPubMed

Acampora D, D’Esposito M, Faiella A, Pannese M, Migliaccio E, Morelli F, et al. The human HOX gene family. Nucleic Acids Res. 1989;17(24):10385–402.CrossRefPubMedPubMedCentral

Burke AC, Nelson CE, Morgan BA, Tabin C. Hox genes and the evolution of vertebrate axial morphology. Development. 1995;121(2):333–46.PubMed

Duboule D. The vertebrate limb: a model system to study the Hox/HOM gene network during development and evolution. Bioessays. 1992;14(6):375–84.CrossRefPubMed

Maroulakou IG, Spyropoulos DD. The study of HOX gene function in hematopoietic, breast and lung carcinogenesis. Anticancer Res. 2003;23(3A):2101–10.PubMed

De Vita G, Barba P, Odartchenko N, Givel JC, Freschi G, Bucciarelli G, et al. Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur J Cancer. 1993;29A(6):887–93.CrossRefPubMed

10.

Cantile M, Scognamiglio G, La Sala L, La Mantia E, Scaramuzza V, Valentino E, et al. Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers. Int J Mol Sci. 2013;14(11):21727–40.CrossRefPubMedPubMedCentral

11.

Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 2015;24(10):1574–84.CrossRefPubMedPubMedCentral

12.

Cillo C, Schiavo G, Cantile M, Bihl MP, Sorrentino P, Carafa V, et al. The HOX gene network in hepatocellular carcinoma. Int J Cancer. 2014;129(11):2577–87.CrossRef

13.

Morgan R, Boxall A, Harrington KJ, Simpson GR, Michael A, Pandha HS. Targeting HOX transcription factors in prostate cancer. BMC Urol. 2014;14:17.CrossRefPubMedPubMedCentral

14.

Scott V, Morgan EA, Stadler HS. Genitourinary functions of Hoxa13 and Hoxd13. J Biochem. 2005;137(6):671–6.CrossRefPubMed

15.

Pan TT, Jia WD, Yao QY, Sun QK, Ren WH, Huang M, et al. Overexpression of HOXA13 as a potential marker for diagnosis and poor prognosis of hepatocellular carcinoma. Tohoku J Exp Med. 2014;234(3):209–19.CrossRefPubMed

16.

Han Y, Tu WW, Wen YG, Li DP, Qiu GQ, Tang HM, et al. Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry. Med Oncol. 2013;30(2):564.CrossRefPubMed

17.

Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H, et al. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. J Transl Med. 2015;13:84.CrossRefPubMedPubMedCentral

18.

Duan R, Han L, Wang Q, Wei J, Chen L, Zhang J, et al. HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways. Oncotarget. 2015;6(29):27778–93.CrossRefPubMedPubMedCentral

19.

Ma RL, Shen LY, Chen KN. Coexpression of ANXA2, SOD2 and HOXA13 predicts poor prognosis of esophageal squamous cell carcinoma. Oncol Rep. 2014;31(5):2157–64.PubMed

20.

Guo B, Che T, Shi B, Guo L, Zhang Z, Li L, et al. Interaction network analysis of differentially expressed genes and screening of cancer marker in the urine of patients with invasive bladder cancer. Int J Clin Exp Med. 2015;8(3):3619–28.PubMedPubMedCentral

21.

Guo B, Che T, Shi B, Guo L, Yin Y, Li L, et al. Screening and identification of specific markers for bladder transitional cell carcinoma from urine urothelial cells with suppressive subtractive hybridization and cDNA microarray. Can Urol Assoc J. 2011;5(6):E129–37.CrossRefPubMedPubMedCentral

22.

Holyoake A, O’Sullivan P, Pollock R, Best T, Watanabe J, Kajita Y, et al. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder. Clin Cancer Res. 2008;14(3):742–9.CrossRefPubMed

Titel: Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer
verfasst von: Haiyi Hu
Yuebing Chen
Sheng Cheng
Gonghui Li
Zhigen Zhang
Publikationsdatum: 01.06.2017
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 11-12/2017
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-016-1108-4

Springer Medizin Österreich

Summary

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11-12/2017

MedUni Wien Researcher of the Month Juni 2017

Prognostic nutritional index as a predictor of prognosis in patients with diffuse large B cell lymphoma

Malignant mixed müllerian tumor mimicking cervical carcinoma

A 5‑year update of patients with HPV positive versus negative oropharyngeal cancer after radiochemotherapy in Austria

Abiraterone for castration-resistant prostate cancer: adherence, survival and hospitalization

Comparison of rapid hybridization-based pathogen identification and resistance evaluation in sepsis using the Verigene® device paired with “good old culture”